These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27634665)

  • 1. Women's experiences of having an early medical abortion at home.
    Hedqvist M; Brolin L; Tydén T; Larsson M
    Sex Reprod Healthc; 2016 Oct; 9():48-54. PubMed ID: 27634665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile phone messages to provide support to women during the home phase of medical abortion in South Africa: a randomised controlled trial.
    Constant D; de Tolly K; Harries J; Myer L
    Contraception; 2014 Sep; 90(3):226-33. PubMed ID: 24850188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's satisfaction with early home medical abortion with telephone follow-up: a questionnaire-based study in the U.K.
    McKay RJ; Rutherford L
    J Obstet Gynaecol; 2013 Aug; 33(6):601-4. PubMed ID: 23919859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain during medical abortion: a multicenter study in France.
    Saurel-Cubizolles MJ; Opatowski M; David P; Bardy F; Dunbavand A
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():212-7. PubMed ID: 26448133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's opinions on the home management of early medical abortion in the UK.
    Lohr PA; Wade J; Riley L; Fitzgibbon A; Furedi A
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):21-5. PubMed ID: 20067668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's satisfaction with medical termination.
    Maaita ME; Prasarman C; Smith J; Neale EJ
    Br J Fam Plann; 1999 Apr; 25(1):9-11. PubMed ID: 10228242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
    Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's experiences of the final stage of early medical abortion at home: results of a pilot survey.
    Cameron S; Glasier A; Dewart H; Johnstone A
    J Fam Plann Reprod Health Care; 2010 Oct; 36(4):213-6. PubMed ID: 21067636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol.
    Elul B; Pearlman E; Sorhaindo A; Simonds W; Westhoff C
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):169-72. PubMed ID: 10846331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study supports the introduction of early medical abortion in Turkey.
    Akin A; Kocoglu GO; Akin L
    Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers around access to abortion experienced by rural women in New South Wales, Australia.
    Doran FM; Hornibrook J
    Rural Remote Health; 2016; 16(1):3538. PubMed ID: 26987999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective open-label study of home use of mifepristone for medical abortion in Nepal.
    Conkling K; Karki C; Tuladhar H; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2015 Mar; 128(3):220-3. PubMed ID: 25482435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.